This review maps the complete pharmacology of human appetite — from leptin and hypothalamic circuits to gut peptides (GLP-1, PYY, CCK, ghrelin) — identifying the most promising drug targets for obesity treatment.
Key findingHuman appetite is regulated by a multi-level system including adiposity signals (leptin, insulin), gut peptides (GLP-1, PYY, CCK, ghrelin), and hypoth
What the researchers found
Human appetite is regulated by a multi-level system including adiposity signals (leptin, insulin), gut peptides (GLP-1, PYY, CCK, ghrelin), and hypothalamic neuropeptides (NPY, AgRP, POMC), with GLP-1 and PYY identified as the most druggable targets.
Why it matters
Advances understanding of glp-1, neuropeptides, weight-loss, receptor-signaling with translational implications.
How the study worked
review study examining glp-1 and neuropeptides.
What this study cannot tell us
Study-specific limitations apply; see abstract for details.
How to read the evidence
moderate evidence from review study design.
When this study was published
Published in 2004.
The bigger picture
Contributes to the growing body of peptide research with implications for clinical development and therapeutic applications.
Questions still open
- Further research needed to confirm and extend these findings.
- Clinical translation and safety need evaluation.
- Optimal dosing and delivery require characterization.
Common questions
What was the main focus of this study?
What was discovered?
Read the original research
The pharmacology of human appetite expression.
Current drug targets, 5(3), 221-40
Citation
Halford, Jason C G; Cooper, Gillian D; Dovey, Terence M. (2004). The pharmacology of human appetite expression.. Current drug targets, 5(3), 221-40.